Jose‐Alberto Palma

ORCID: 0000-0002-1345-6774
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Parkinson's Disease Mechanisms and Treatments
  • Hereditary Neurological Disorders
  • Cardiovascular Syncope and Autonomic Disorders
  • Botulinum Toxin and Related Neurological Disorders
  • Genetic Neurodegenerative Diseases
  • Neurological disorders and treatments
  • Neurological diseases and metabolism
  • Heart Rate Variability and Autonomic Control
  • Obstructive Sleep Apnea Research
  • Neuroscience of respiration and sleep
  • Migraine and Headache Studies
  • Endoplasmic Reticulum Stress and Disease
  • RNA regulation and disease
  • Peripheral Neuropathies and Disorders
  • Alzheimer's disease research and treatments
  • Mitochondrial Function and Pathology
  • Sleep and Wakefulness Research
  • Organ Donation and Transplantation
  • Neurogenetic and Muscular Disorders Research
  • Autoimmune Neurological Disorders and Treatments
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Cellular Mechanics and Interactions
  • Neurology and Historical Studies
  • Neurological Complications and Syndromes
  • History of Medicine Studies

New York University
2015-2024

Novartis (United States)
2024

University of California, San Francisco
2024

Dysautonomia Foundation
2013-2023

University of Colorado Anschutz Medical Campus
2023

Beth Israel Deaconess Medical Center
2023

University of Bologna
2022

NYU Langone Health
2017-2022

University Medical Center
2013-2022

Istituto delle Scienze Neurologiche di Bologna
2022

Ruth Chia Marya S. Sabir Sara Bandrés‐Ciga Sara Sáez-Atiénzar Regina H. Reynolds and 95 more Emil K. Gustavsson Ronald L. Walton Sarah Ahmed Coralie Viollet Jinhui Ding Mary B. Makarious Mónica Díez-Fairén Makayla K. Portley Zalak Shah Yevgeniya Abramzon Dena Hernández Cornelis Blauwendraat David J. Stone John D. Eicher Laura Parkkinen Olaf Ansorge Lorraine N. Clark Lawrence S. Honig Karen Marder Afina W. Lemstra Peter St George‐Hyslop Elisabet Londos Kevin Morgan Tammaryn Lashley Thomas T. Warner Zane Jaunmuktane Douglas Galasko Isabel Santana Pentti J. Tienari Liisa Myllykangas Minna Oinas Nigel J. Cairns John C. Morris Glenda M. Halliday Vivianna M. Van Deerlin John Q. Trojanowski Maurizio Grassano Andrea Calvo Gabriele Mora Antonio Canosa Gianluca Floris Ryan C. Bohannan Francesca Brett Ziv Gan‐Or Joshua T. Geiger Anni Moore Patrick May Rejko Krüger David S. Goldstein Grisel Lopez Nahid Tayebi Ellen Sidransky Anthony R. Sotis Gauthaman Sukumar Camille Alba Nathaniel M. Lott Elisa McGrath Martinez Meila Tuck Jatinder Singh Dagmar Bačíková Xijun Zhang Daniel Hupalo Adelani Adeleye Matthew D. Wilkerson Harvey B. Pollard Lucy Norcliffe‐Kaufmann Jose‐Alberto Palma Horacio Kaufmann Vikram G. Shakkottai Matthew Perkins Kathy L. Newell Thomas Gasser Claudia Schulte Francesco Landi Erika Salvi Daniele Cusi Eliezer Masliah Ronald C. Kim Chad A. Caraway Edwin S. Monuki Maura Brunetti Ted M. Dawson Liana S. Rosenthal Marilyn S. Albert Olga Pletnikova Juan C. Troncoso Margaret E. Flanagan Qinwen Mao Eileen H. Bigio Eloy Rodríguez‐Rodríguez Jon Infante Carmen Lage Isabel González Aramburu Pascual Sánchez-Juan Bernardino Ghetti

10.1038/s41588-021-00785-3 article EN Nature Genetics 2021-02-15

To define the clinical features and biomarkers that predict which patients with pure autonomic failure will develop Parkinson disease, dementia Lewy bodies, or multiple system atrophy.One hundred who presented were recruited at 5 medical centers in United States. Seventy-four agreed to be followed prospectively. Patients underwent evaluations including neurological rating scales, sleep questionnaires, smell test, sympathetic parasympathetic cardiovascular function tests.At enrollment, 68 ±...

10.1002/ana.24877 article EN Annals of Neurology 2017-01-17

Objective Blunted tachycardia during hypotension is a characteristic feature of patients with autonomic failure, but the range has not been defined. This study reports orthostatic heart rate (HR) changes in failure caused by neurodegenerative synucleinopathies. Methods Patients evaluated at sites U.S. Autonomic Consortium (NCT01799915) underwent standardized function tests and full neurological evaluation. Results We identified 402 (OH) who had normal sinus rhythm. Of these, 378 impaired...

10.1002/ana.25170 article EN Annals of Neurology 2018-02-05

The diagnosis of Parkinson's disease (PD) and atypical parkinsonian syndromes is difficult due to the lack reliable, easily accessible biomarkers. Multiple system atrophy (MSA) a synucleinopathy whose symptoms often overlap with PD. Exosomes isolated from blood by immunoprecipitation using CNS markers provide window into brain's biochemistry may assist in distinguishing between PD MSA. Thus, we asked whether α-synuclein (α-syn) such exosomes could distinguish among healthy individuals,...

10.1007/s00401-021-02324-0 article EN cc-by Acta Neuropathologica 2021-05-15

Multiple system atrophy (MSA) is a progressive neurodegenerative disorder caused by the abnormal accumulation of α-synuclein in nervous system. Clinical features include autonomic and motor dysfunction, which overlap with those Parkinson disease (PD), particularly at early stages. There an unmet need for accurate diagnostic prognostic biomarkers MSA and, specifically, critical to distinguish from other synucleinopathies, PD. The purpose study was develop unique cutaneous pathologic signature...

10.1212/wnl.0000000000206772 article EN Neurology 2023-01-19

ABSTRACT Orthostatic hypotension (OH) is frequent in patients with Parkinson's disease (PD) and can occur or without symptoms. Pharmacological treatments are effective, but often exacerbate supine hypertension. Guidelines exist for the diagnosis, not treatment of OH. We examined relationship between blood pressure (BP) symptoms a cohort PD goal identifying hemodynamic target to guide treatment. measured BP upright (tilt active standing) identified presence absence symptomatic OH by using...

10.1002/mds.26079 article EN Movement Disorders 2015-02-12
Ruth Chia Anindita Ray Zalak Shah Jinhui Ding Paola Ruffo and 95 more Masashi Fujita Vilas Menon Sara Sáez-Atiénzar Paolo Reho Karri Kaivola Ronald L. Walton Regina H. Reynolds Ramita Karra S.S.J. Sait Fulya Akçimen Mónica Díez-Fairén Ignacio Álvarez Alessandra Fanciulli Nadia Stefanova Klaus Seppi Susanne Duerr Fabian Leys Florian Krismer Victoria Sidoroff Alexander Zimprich Walter Pirker Olivier Rascol Alexandra Foubert‐Samier Wassilios G. Meissner François Tison Anne Pavy‐Le Traon Maria Teresa Pellecchia Paolo Barone Maria Claudia Russillo Juan Marín‐Lahoz Jaime Kulisevsky Soraya Torres Pablo Mir María Teresa Periñán Christos Proukakis Viorica Chelban Lesley Wu Yee Yen Goh Laura Parkkinen Joshua Shulman Christopher Kobylecki Jennifer A. Saxon Sara Rollinson Emily M. Garland Italo Biaggioni Irene Litvan Ileana Gabriela Sanchez Rubio Roy N. Alcalay Kimberly Kwei Steven Lubbe Qinwen Mao Margaret E. Flanagan Rudolph J. Castellani Vikram Khurana Alain Ndayisaba Andrea Calvo Gabriele Mora Antonio Canosa Gianluca Floris Ryan C. Bohannan Anni Moore Lucy Norcliffe‐Kaufmann Jose‐Alberto Palma Horacio Kaufmann Changyoun Kim Michiyo Iba Eliezer Masliah Ted M. Dawson Liana S. Rosenthal Alexander Pantelyat Marilyn S. Albert Olga Pletniková Juan C. Troncoso Jon Infante Carmen Lage Pascual Sánchez‐Juan Geidy E. Serrano Thomas G. Beach Pau Pástor Huw R. Morris Diego Albani Jordi Clarimón Gregor K. Wenning John Hardy Mina Ryten Eric Topol Ali Torkamani Adriano Chiò David A. Bennett Philip L. De Jager Philip Low Wolfgang Singer William P. Cheshire Zbigniew K. Wszołek Dennis W. Dickson

Highlights•Generation of a foundational genomic resource in multiple system atrophy•GWAS identifies novel risk loci at GAB1, lnc-LRRC49-3, TENM2, and RABGEF1•Functional genomics implicates USP38-DT, KCTD7, lnc-KCTD7-2 within these loci•Gene-burden analysis nominal enrichment rare missense mutations KCTD7SummaryMultiple atrophy (MSA) is an adult-onset, sporadic synucleinopathy characterized by parkinsonism, cerebellar ataxia, dysautonomia. The genetic architecture MSA poorly understood,...

10.1016/j.neuron.2024.04.002 article EN cc-by-nc-nd Neuron 2024-05-02

Abstract We aimed to describe the clinical features of patients with pure autonomic failure (PAF) preceding phenoconversion that could be useful as predictive markers for advancing α-synuclein-associated neurodegeneration brain. Patients diagnosed PAF were evaluated at eight centres (seven US-based and one European) enrolled in a longitudinal observational cohort study (NCT01799915). Subjects underwent detailed assessments motor, sleep, olfactory, cognitive function followed prospectively...

10.1093/brain/awae033 article EN Brain 2024-02-15

Many migraineurs who seek care in headache clinics are refractory to treatment, despite advances therapies. Epidemiology is poorly characterized, because diagnostic criteria for migraine were not available until recently. We aimed determine the frequency of patients attended Headache Unit a tertiary center, according recently proposed criteria.The study population consisted consecutive sample 370 (60.8% females) with mean age 43 years (range 14-86) evaluated first time our unit over one-year...

10.1186/1471-2377-11-94 article EN cc-by BMC Neurology 2011-08-01

Obstructive Sleep Apnea (OSA) is a major risk factor for cardiovascular disease. The goal of this study was to demonstrate whether the use CPAP produces significant changes in heart rate or variability patients with OSA first night treatment and gender obesity play role these differences.Single-center transversal including severe corrected CPAP. Only total correction after were included. Patients underwent two sleep studies on consecutive nights: basal study, second We also analyzed their...

10.1371/journal.pone.0033769 article EN cc-by PLoS ONE 2012-03-16

Neurogenic orthostatic hypotension (nOH) is a fall in blood pressure (BP) on standing due to reduced norepinephrine release from sympathetic nerve terminals. nOH feature of several neurological disorders that affect the autonomic nervous system, most notably Parkinson disease (PD), multiple system atrophy (MSA), pure failure (PAF), and other neuropathies. Droxidopa, an orally active synthetic amino acid converted by enzyme aromatic L-amino decarboxylase (dopa-decarboxylase), was recently...

10.1586/14779072.2015.1057504 article EN Expert Review of Cardiovascular Therapy 2015-06-19

Orthostatic hypotension (OH) is a sustained fall in blood pressure on standing which can cause symptoms of organ hypoperfusion. OH associated with increased morbidity and mortality leads to significant number hospital admissions particularly the elderly (233 per 100,000 patients over 75 years age US). be due volume depletion, loss, large varicose veins, medications, or defective activation sympathetic nerves reduced norepinephrine release upon (i.e., neurogenic OH).

10.1002/mdc3.12478 article EN Movement Disorders Clinical Practice 2017-01-30
Coming Soon ...